These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21194679)

  • 21. Interaction of two hereditary spastic paraplegia gene products, spastin and atlastin, suggests a common pathway for axonal maintenance.
    Evans K; Keller C; Pavur K; Glasgow K; Conn B; Lauring B
    Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10666-71. PubMed ID: 16815977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal dopaminergic nigrostriatal innervation in SPG3A hereditary spastic paraplegia.
    Albin RL; Koeppe RA; Rainier S; Fink JK
    J Neurogenet; 2008; 22(4):289-94. PubMed ID: 19085270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hereditary spastic paraplegia: identification of an SPG3A gene mutation in a Chinese family.
    Chan KY; Ching CK; Mak CM; Lam CW; Chan AY
    Hong Kong Med J; 2009 Aug; 15(4):304-7. PubMed ID: 19652243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atlastin-1, the dynamin-like GTPase responsible for spastic paraplegia SPG3A, remodels lipid membranes and may form tubules and vesicles in the endoplasmic reticulum.
    Muriel MP; Dauphin A; Namekawa M; Gervais A; Brice A; Ruberg M
    J Neurochem; 2009 Sep; 110(5):1607-16. PubMed ID: 19573020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transverse endoplasmic reticulum expansion in hereditary spastic paraplegia corticospinal axons.
    Zhu PP; Hung HF; Batchenkova N; Nixon-Abell J; Henderson J; Zheng P; Renvoisé B; Pang S; Xu CS; Saalfeld S; Funke J; Xie Y; Svara F; Hess HF; Blackstone C
    Hum Mol Genet; 2022 Aug; 31(16):2779-2795. PubMed ID: 35348668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel insertion mutation in atlastin 1 is associated with spastic quadriplegia, increased membrane tethering, and aberrant conformational switching.
    Kelly CM; Zeiger PJ; Narayanan V; Ramsey K; Sondermann H
    J Biol Chem; 2022 Jan; 298(1):101438. PubMed ID: 34808209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ER network formation and membrane fusion by atlastin1/SPG3A disease variants.
    Ulengin I; Park JJ; Lee TH
    Mol Biol Cell; 2015 May; 26(9):1616-28. PubMed ID: 25761634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation screening of spastin, atlastin, and REEP1 in hereditary spastic paraplegia.
    McCorquodale DS; Ozomaro U; Huang J; Montenegro G; Kushman A; Citrigno L; Price J; Speziani F; Pericak-Vance MA; Züchner S
    Clin Genet; 2011 Jun; 79(6):523-30. PubMed ID: 20718791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular localization, oligomerization, and membrane association of the hereditary spastic paraplegia 3A (SPG3A) protein atlastin.
    Zhu PP; Patterson A; Lavoie B; Stadler J; Shoeb M; Patel R; Blackstone C
    J Biol Chem; 2003 Dec; 278(49):49063-71. PubMed ID: 14506257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation analysis of SPG4 and SPG3A genes and its implication in molecular diagnosis of Korean patients with hereditary spastic paraplegia.
    Park SY; Ki CS; Kim HJ; Kim JW; Sung DH; Kim BJ; Lee WY
    Arch Neurol; 2005 Jul; 62(7):1118-21. PubMed ID: 16009769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SPG3A: An additional family carrying a new atlastin mutation.
    Tessa A; Casali C; Damiano M; Bruno C; Fortini D; Patrono C; Cricchi F; Valoppi M; Nappi G; Amabile GA; Bertini E; Santorelli FM
    Neurology; 2002 Dec; 59(12):2002-5. PubMed ID: 12499504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult-onset autosomal dominant spastic paraplegia linked to a GTPase-effector domain mutation of dynamin 2.
    Sambuughin N; Goldfarb LG; Sivtseva TM; Davydova TK; Vladimirtsev VA; Osakovskiy VL; Danilova AP; Nikitina RS; Ylakhova AN; Diachkovskaya MP; Sundborger AC; Renwick NM; Platonov FA; Hinshaw JE; Toro C
    BMC Neurol; 2015 Oct; 15():223. PubMed ID: 26517984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary spastic paraplegia-causing mutations in atlastin-1 interfere with BMPRII trafficking.
    Zhao J; Hedera P
    Mol Cell Neurosci; 2013 Jan; 52():87-96. PubMed ID: 23079343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SPTLC1 mutation in twin sisters with hereditary sensory neuropathy type I.
    Verhoeven K; Coen K; De Vriendt E; Jacobs A; Van Gerwen V; Smouts I; Pou-Serradell A; Martin JJ; Timmerman V; De Jonghe P
    Neurology; 2004 Mar; 62(6):1001-2. PubMed ID: 15037712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exclusion of serine palmitoyltransferase long chain base subunit 2 (SPTLC2) as a common cause for hereditary sensory neuropathy.
    Dawkins JL; Brahmbhatt S; Auer-Grumbach M; Wagner K; Hartung HP; Verhoeven K; Timmerman V; De Jonghe P; Kennerson M; LeGuern E; Nicholson GA
    Neuromuscul Disord; 2002 Oct; 12(7-8):656-8. PubMed ID: 12207934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary spastic paraplegia associated with axonal neuropathy: a novel mutation of SPG3A in a large family.
    Al-Maawali A; Rolfs A; Klingenhaeger M; Yoon G
    J Clin Neuromuscul Dis; 2011 Mar; 12(3):143-6. PubMed ID: 21321493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel mutation in the SPG3A gene (atlastin) in hereditary spastic paraplegia.
    Matsui M; Kawarai T; Hase Y; Tomimoto H; Iseki K; Rogaeva E; Orlacchio A; Bernardi G; St George-Hyslop P; Takahashi R; Matsui M
    J Neurol; 2007 Jul; 254(7):972-4. PubMed ID: 17380240
    [No Abstract]   [Full Text] [Related]  

  • 38. Fine mapping of the hereditary sensory neuropathy type I locus on chromosome 9q22.1-->q22.3: exclusion of GAS1 and XPA.
    Blair IP; Dawkins JL; Nicholson GA
    Cytogenet Cell Genet; 1997; 78(2):140-4. PubMed ID: 9371409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and genetic characterization of hereditary spastic paraplegia type 3A in Taiwan.
    Hsu SL; Hsueh HW; Chen SY; Chang YY; Tan S; Hong CT; Tsai YS; Yu KW; Wu HM; Liao YC; Soong BW; Hu CJ; Lan MY; Lee YC
    Parkinsonism Relat Disord; 2021 Jun; 87():87-91. PubMed ID: 34015694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of HSP-causing mutations in SPG3A and NIPA1 on the assembly, trafficking, and interaction between atlastin-1 and NIPA1.
    Botzolakis EJ; Zhao J; Gurba KN; Macdonald RL; Hedera P
    Mol Cell Neurosci; 2011 Jan; 46(1):122-35. PubMed ID: 20816793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.